Application

17378565 · ANTI-ALPHA-4-BETA-7 ANTIBODIES

Filed 2021-07-16 · Granted · Patent 11639390 (2023-05-02) The official file ↗The patent and its PDF ↗ · Art unit 1644 · Examiner Maher M Haddad Typical · CPC C07K 16/2839 · AbbVie Inc. · Clark+Elbing LLP - Abbvie

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

14.6 mo

to disposition 21.5 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.